Name: IO Biotech, Inc. (IOBT) Financial Statements
Creator: FinSpry

IO Biotech Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

IO Biotech, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.85	0.00	0.00	0.00	0.00
Gross Profit	-0.85	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	71.48	67.83	46.99	30.15	8.46
Selling, General & Administrative	23.69	23.61	24.44	11.08	1.68
Operating Expenses	95.18	91.44	71.42	41.23	10.15
Operating Income	-95.18	-91.44	-71.42	-41.23	-10.15
Other Income/Expense
Interest Income	4.72	5.88	1.41	0.00	0.00
Interest Expense	0.00	0.00	-0.30	-0.36	-0.03
Other Income/Expense	-3.59	0.33	0.13	-26.22	0.00
Income
Income Before Tax	-94.05	-85.23	-70.19	-67.81	-12.04
Income Tax Expense	1.44	0.85	1.27	0.07	0.00
Net Income	-95.49	-86.08	-71.46	-67.88	-12.04
Net Income - Continuous Operations	-95.49	-86.08	-71.46	-67.88	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-94.92	-84.48	-69.34	-41.23	0.00
EBIT	-95.18	-85.23	-69.88	-41.23	-10.15
Depreciation & Amortization	0.25	0.20	0.10	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-2.00	-2.00	-17.00	-82.00
Diluted EPS	-1.00	-2.00	-2.00	-17.00	-82.00
Basic Shares Outstanding	65.88	43.54	28.82	4.34	0.18
Diluted Shares Outstanding	65.88	43.54	28.82	4.34	0.18